| Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model TF Rogers, F Zhao, D Huang, N Beutler, A Burns, W He, O Limbo, C Smith, ... Science 369 (6506), 956-963, 2020 | 1335 | 2020 |
| Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection G Song, W He, S Callaghan, F Anzanello, D Huang, J Ricketts, JL Torres, ... Nature communications 12 (1), 2938, 2021 | 271 | 2021 |
| A broadly neutralizing antibody targets the dynamic HIV envelope trimer apex via a long, rigidified, and anionic β-hairpin structure JH Lee, R Andrabi, CY Su, A Yasmeen, JP Julien, L Kong, NC Wu, ... Immunity 46 (4), 690-702, 2017 | 232 | 2017 |
| Global site-specific N-glycosylation analysis of HIV envelope glycoprotein L Cao, JK Diedrich, DW Kulp, M Pauthner, L He, SKR Park, D Sok, CY Su, ... Nature communications 8 (1), 14954, 2017 | 223 | 2017 |
| Identification of common features in prototype broadly neutralizing antibodies to HIV envelope V2 apex to facilitate vaccine design R Andrabi, JE Voss, CH Liang, B Briney, LE McCoy, CY Wu, CH Wong, ... Immunity 43 (5), 959-973, 2015 | 195 | 2015 |
| A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection P Zhou, M Yuan, G Song, N Beutler, N Shaabani, D Huang, W He, X Zhu, ... Science translational medicine 14 (637), eabi9215, 2022 | 128 | 2022 |
| Differential processing of HIV envelope glycans on the virus and soluble recombinant trimer L Cao, M Pauthner, R Andrabi, K Rantalainen, Z Berndsen, JK Diedrich, ... Nature communications 9 (1), 3693, 2018 | 126 | 2018 |
| Strategies for a multi-stage neutralizing antibody-based HIV vaccine R Andrabi, JN Bhiman, DR Burton Current opinion in immunology 53, 143-151, 2018 | 97 | 2018 |
| Reprogramming the antigen specificity of B cells using genome-editing technologies JE Voss, A Gonzalez-Martin, R Andrabi, RP Fuller, B Murrell, LE McCoy, ... Elife 8, e42995, 2019 | 78 | 2019 |
| Elicitation of neutralizing antibodies targeting the V2 apex of the HIV envelope trimer in a wild-type animal model JE Voss, R Andrabi, LE McCoy, N de Val, RP Fuller, T Messmer, CY Su, ... Cell reports 21 (1), 222-235, 2017 | 68 | 2017 |
| A pseudovirus system enables deep mutational scanning of the full SARS-CoV-2 spike B Dadonaite, KHD Crawford, CE Radford, AG Farrell, CY Timothy, ... Cell 186 (6), 1263-1278. e20, 2023 | 62 | 2023 |
| Site-specific steric control of SARS-CoV-2 spike glycosylation JD Allen, H Chawla, F Samsudin, L Zuzic, AT Shivgan, Y Watanabe, ... Biochemistry 60 (27), 2153-2169, 2021 | 62 | 2021 |
| Glycans function as anchors for antibodies and help drive HIV broadly neutralizing antibody development R Andrabi, CY Su, CH Liang, SS Shivatare, B Briney, JE Voss, SK Nawazi, ... Immunity 47 (3), 524-537. e3, 2017 | 61 | 2017 |
| Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease P Zhou, G Song, H Liu, M Yuan, W He, N Beutler, X Zhu, VT Longping, ... Immunity 56 (3), 669-686. e7, 2023 | 47 | 2023 |
| Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit NK Hurlburt, LJ Homad, I Sinha, MF Jennewein, AJ MacCamy, YH Wan, ... Communications biology 5 (1), 342, 2022 | 47 | 2022 |
| Targeted isolation of diverse human protective broadly neutralizing antibodies against SARS-like viruses W He, R Musharrafieh, G Song, K Dueker, LV Tse, DR Martinez, ... Nature immunology 23 (6), 960-970, 2022 | 40 | 2022 |
| A broad and potent neutralization epitope in SARS-related coronaviruses M Yuan, X Zhu, W He, P Zhou, CI Kaku, T Capozzola, CY Zhu, X Yu, H Liu, ... Proceedings of the National Academy of Sciences 119 (29), e2205784119, 2022 | 38 | 2022 |
| Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunization HL Turner, R Andrabi, CA Cottrell, ST Richey, G Song, S Callaghan, ... Science advances 7 (31), eabh2791, 2021 | 37 | 2021 |
| Long-term suppression of HIV-1C virus production in human peripheral blood mononuclear cells by LTR heterochromatization with a short double-stranded RNA A Singh, JK Palanichamy, P Ramalingam, MA Kassab, M Bhagat, ... Journal of Antimicrobial Chemotherapy 69 (2), 404-415, 2014 | 37 | 2014 |
| A protective broadly cross-reactive human antibody defines a conserved site of vulnerability on beta-coronavirus spikes P Zhou, M Yuan, G Song, N Beutler, N Shaabani, D Huang, W He, X Zhu, ... | 34 | 2021 |
Andrew B. WardThe Scripps Research InstituteVerified email at scripps.edu
